Critical Path Public Private Partnerships Clinical Trials Optional
Summary
The grant aims to support the maintenance and management of existing consortia groups established by the Critical Path Institute, focusing on innovative projects in research, education, and outreach to enhance drug product innovation and development. Eligible applicants include organizations associated with the Critical Path Institute. To apply, interested parties should contact the FDA via email at terrin.brown@fda.hhs.gov for further information.
Full description
Description
The FDA seeks an application to continue to maintain, manage existing consortia groups convened and established by the Critical Path Institute. This is a renewal of the cooperative agreement #5U18FD005320 as part of the Critical Path Initiative. This is in support of Critical Path Initiative introduced in Section 566 of the Federal Food, Drug, and Cosmetic Act. This includes developing innovative, collaborative projects in research, education, and outreach for fostering drug product innovation, enabling the acceleration of development, manufacturing, and translational therapeutics, enhancing safety, efficacy, quality, and performance. This funding opportunity will provide support, depending on availability of FDA funding.
Eligibility
Eligible applicants
Miscellaneous
- Other
Additional information
Grantor contact information
Description
terrin.brown@fda.hhs.gov
Recommended Resource
Grant Writing Services on Fiverr
Struggling with grant applications? Get expert help from professional freelance writers on Fiverr — from research and proposal drafts to compliance review and submission. Secure funding faster with proven talent.
Get started now